Effects of nitric oxide on cell proliferation: Novel insights

Journal of the American College of Cardiology

Volumn 62, Issue 2, 2013, Pages 89-95

  Napoli, Claudio ^a,b   Paolisso, Giuseppe ^a   Casamassimi, Amelia ^a   Al Omran, Mohammed ^c   Barbieri, Michelangela ^a   Sommese, Linda ^a   Infante, Teresa ^b   Ignarro, Louis J ^d  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b IRCCS SDN   (Italy)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular diseases; cell cycle; cell proliferation; diagnostic and therapeutic tools; imaging; nitric oxide; type 2 diabetes

Indexed keywords

DIBUTYRYL CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; DIABETES MELLITUS; DISEASE ACTIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL RESPIRATION; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; SIGNAL TRANSDUCTION; STEM CELL;

EID: 84879821852     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.070     Document Type: Review

References (84)

1. C. Napoli, and L.J. Ignarro Nitric oxide and atherosclerosis Nitric Oxide 5 2001 88 97
2. K. Bian, and F. Murad Nitric oxide (NO) - biogeneration, regulation, and relevance to human diseases Front Biosci 8 2003 d264 d278
3. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochem J 357 2001 593 615
4. R.F. Furchgott Introduction to EDRF research J Cardiovasc Pharmacol 22 Suppl 7 1993 S1 S2
5. J.O. Lundberg, and E. Weitzberg NO generation from inorganic nitrate and nitrite: Role in physiology, nutrition and therapeutics Arch Pharm Res 32 2009 1119 1126
6. D.D. Thomas, L.A. Ridnour, and J.S. Isenberg The chemical biology of nitric oxide: implications in cellular signaling Free Radic Biol Med 45 2008 18 31
7. F.C. Tanner, P. Meier, H. Greutert, C. Champion, E.G. Nabel, and T.F. Lüscher Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation Circulation 101 2000 1982 1989
8. A. Villalobo Nitric oxide and cell proliferation FEBS J 273 2006 2329 2344
9. X. Cui, J. Zhang, and P. Ma cGMP-independent nitric oxide signaling and regulation of the cell cycle BMC Genomics 6 2005 151
10. X. Su, A. Takahashi, and N. Kondo Nitric oxide radical-induced radioadaptation and radiosensitization are G2/M phase-dependent J Radiat Res 52 2011 609 615
11. C. Napoli, G. Cirino, and P. Del Soldato Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice Proc Natl Acad Sci U S A 98 2001 2860 2864
12. Waf1/Cip1/Sdi1 in vascular smooth muscle cells Mol Pharmacol 56 1999 938 946
13. P.M. Bauer, G.M. Buga, J.M. Fukuto, A.E. Pegg, and L.J. Ignarro Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cystein 360 in the active site of the enzyme J Biol Chem 276 2001 34458 34464
14. M. Gu, J. Lynch, and P. Brecher Nitric oxide increases p21Waf1/Cip1 expression by a cGMP-dependent pathway that includes activation of extracellular signal-regulated kinase and p70S6k J Biol Chem 275 2000 11389 11396
15. G. Condorelli, J.K. Aycock, G. Frati, and C. Napoli Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice FASEB J 15 2001 2162 2170
16. M.R. Kibbe, J. Li, and S. Nie Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate J Vasc Surg 31 2000 1214 1228
17. Y. Maeda, U. Ikeda, and K.I. Oya Endogenously generated nitric oxide by nitric-oxide synthase gene transfer inhibits cellular proliferation J Pharmacol Exp Ther 292 2000 387 393
18. P.K. Vadiveloo, E. Keramidaris, W.A. Morrison, and A.G. Stewart Lipopolysaccharide-induced cell cycle arrest in macrophages occurs independently of nitric oxide synthase II induction Biochim Biophys Acta 1539 2001 140 146
19. U.C. Garg, and A. Hassid Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism Biochem Biophys Res Commun 171 1990 474 479
20. M.R. Kapadia, J.W. Eng, Q. Jiang, D.A. Stoyanovsky, and M.R. Kibbe Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells Nitric Oxide 20 2009 279 288
21. J.R. Tejedo, R. Tapia-Limonchi, and S. Mora-Castilla Low concentrations of nitric oxide delay the differentiation of embryonic stem cells and promote their survival Cell Death Dis 1 2010 e80
22. K. Bian, Y. Ke, Y. Kamisaki, and F. Murad Proteomic modification by nitric oxide J Pharmacol Sci 101 2006 271 279
23. A. Martínez-Ruiz, S. Cadenas, and S. Lamas Nitric oxide signaling: classical, less classical, and nonclassical mechanisms Free Radic Biol Med 51 2011 17 29
24. L. Chen, G. Daum, and K. Chitaley Vasolidator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells Arterioscler Thromb Vasc Bio 24 2004 1403 1408
25. S.M. Yu, L.M. Hung, and C.C. Lin cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway Circulation 95 1997 1269 1277
26. P. Pifarré, M.A. Baltrons, I. Földi, and A. García NO-sensitive guanylyl cyclase beta1 subunit is peripherally associated to chromosomes during mitosis. Novel role in chromatin condensation and cell cycle progression Int J Biochem Cell Biol 41 2009 1719 1730
27. B. Illi, C. Dello Russo, and C. Colussi Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling Circ Res 102 2008 51 58
28. R. Heller, T. Polack, R. Gräbner, and U. Till Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP Atherosclerosis 144 1999 49 57
29. O. Kosonen, H. Kankaanranta, P. Vuorinen, and E. Moilanen Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives Eur J Pharmacol 337 1997 55 61
30. R. Sarkar, D. Gordon, J.C. Stanley, and R.C. Webb Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells J Hypertens 15 1997 275 283
31. B. Lima, M.T. Forrester, D.T. Hess, and J.S. Stamler S-nitrosylation in cardiovascular signaling Circ Res 106 2010 633 646
32. I.H. Schulman, and J.M. Hare Regulation of cardiovascular cellular processes by S-nitrosylation Biochim Biophys Acta 1820 2012 752 762
33. W.L. Batista, F.T. Ogata, and M.F. Curcio S-nitrosoglutathione and endothelial nitric oxide synthase-derived nitric oxide regulate compartmentalized Ras S-nitrosylation and stimulate cell proliferation Antioxid Redox Signal 18 2013 221 238
34. C.A. Chen, T.Y. Wang, and S. Varadharaj S-glutathionylation uncouples eNOS and regulates its cellular and vascular function Nature 468 2010 1115 1118
35. M. Jia, C. Mateoiu, and S. Souchelnytskyi Protein tyrosine nitration in the cell cycle Biochem Biophys Res Commun 413 2011 270 276
36. M.C. Carreras, and J.J. Poderoso Mitochondrial nitric oxide in the signaling of cell integrated responses Am J Physiol Cell Physiol 292 2007 C1569 C1580
37. V. Borutaite, R. Morkuniene, O. Arandarcikaite, A. Jekabsone, J. Barauskaite, and G.C. Brown Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release J Biomed Sci 16 2009 70
38. J.D. Erusalimsky, and S. Moncada Nitric oxide and mitochondrial signaling: from physiology to pathophysiology Arterioscler Throm Vasc Biol 27 2007 2524 2531
39. Sdi1/Cip1/Waf1 by nitric oxide-generating vasodilator in vascular smooth muscle cells J Biol Chem 272 1997 10050 10057
40. K.J. Gooch, C.A. Dangler, and J.A. Frangos Exogenous, basal, and flow-induced nitric oxide production and endothelial cell proliferation J Cell Physiol 171 1997 252 258
41. L.J. Ignarro, C. Napoli, and J. Loscalzo Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview Circ Res 90 2002 21 28
42. C. Napoli, and L.J. Ignarro Nitric oxide-releasing drugs Annu Rev Pharmacol Toxicol 47 2003 97 123
43. A. Pautz, J. Art, S. Hahn, S. Nowag, C. Voss, and H. Kleinert Regulation of the expression of inducible nitric oxide synthase Nitric Oxide 23 2010 75 93
44. M.E. Hogg, V.N. Varu, and A.K. Vavra Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status Free Radic Biol Med 50 2011 1065 1074
45. R.V. Sharma, E. Tan, S. Fang, M.V. Gurjar, and R.C. Bhalla NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells Am J Physiol 276 1999 H1450 H1459
46. M. Ishigami, D.K. Swertfeger, M.S. Hui, N.A. Granholm, and D.Y. Hui Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase Arterioscler Thromb Vasc Biol 20 2000 1020 1026
47. C. Pignatti, B. Tantini, and C. Stefanelli Nitric oxide mediates either proliferation or cell death in cardiomyocytes: involvement of polyamines Amino Acids 16 1999 181 190
48. E.L. Taylor, J.T. Li, J.C. Tupper, A.G. Rossi, R.K. Winn, and J.M. Harlan GEA 3162, a peroxynitrite donor, induces Bcl-2-sensitive, p53-independent apoptosis in murine bone marrow cells Biochem Pharmacol 74 2007 1039 1049
49. X. Dai, and J.E. Faber Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis Circ Res 106 2010 1870 1881
50. E. Lepic, D. Burger, X. Lu, W. Song, and Q. Feng Lack of endothelial nitric oxide synthase decreases cardiomyocyte proliferation and delays cardiac maturation Am J Physiol Cell Physiol 291 2006 C1240 C1246
51. J.C. Wong, and R.R. Fiscus Essential roles of the nitric oxide (no)/cGMP/protein kinase G type-Iα (PKG-Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG-Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells J Cell Biochem 112 2011 829 839
52. A. Leri, J. Kajstura, and P. Anversa Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology Circ Res 109 2011 941 961
53. C. Napoli, T. Hayashi, and F. Cacciatore Endothelial progenitor cells as therapeutic agents in the microcirculation: an update Atherosclerosis 215 2011 9 22
54. K. Mujoo, V.G. Sharin, and N.S. Bryan Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells Proc Natl Acad Sci U S A 105 2008 18924 18929
55. N. Ybarra, J.R. del Castillo, and E. Troncy Involvement of the nitric oxide-soluble guanylyl cyclase pathway in the oxytocin-mediated differentiation of porcine bone marrow stem cells into cardiomyocytes Nitric Oxide 24 2011 25 33
56. C. Napoli, S. Williams-Ignarro, and F. de Nigris Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb Proc Natl Acad Sci U S A 102 2005 17202 17206
57. F. de Nigris, M.L. Balestrieri, and S. Williams-Ignarro Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways J Cardiovasc Pharmacol 50 2007 424 433
58. M.L. Balestrieri, S.J. Lu, and F. de Nigris Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention Atherosclerosis 209 2010 403 414
59. C. Napoli, B. Farzati, and V. Sica Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia Eur J Cardiovasc Prev Rehabil 15 2008 709 718
60. A. Casamassimi, V. Grimaldi, and T. Infante Adult stem cells and the clinical arena: are we able to widely use this therapy in patients with chronic limbs arteriopathy and ischemic ulcers without possibility of revascularization? Cardiovasc Hematol Agents Med Chem 10 2012 99 108
61. S. Hamed, B. Brenner, and A. Roguin Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2 Cardiovasc Res 91 2011 9 15
62. G.P. Fadini, M. Miorin, and M. Facco Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus J Am Coll Cardiol 45 2005 1449 1457
63. O.M. Tepper, R.D. Galiano, and J.M. Capla Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures Circulation 106 2002 2781 2786
64. A. Avogaro, G. Toffolo, and E. Kiwanuka L-Arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach Diabetes 52 2003 795 802
65. T. Thum, D. Fraccarollo, and M. Schultheiss Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes Diabetes 56 2007 666 674
66. Y.H. Chen, S.J. Lin, and F.Y. Lin High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms Diabetes 56 2007 1559 1568
67. K. Niwano, M. Arai, K. Tomaru, T. Uchiyama, Y. Ohyama, and M. Kurabayashi Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways Circ Res 93 2003 523 530
68. Y. Miyahara, S. Ohnishi, and H. Obata Beraprost sodium enhances neovascularization in ischemic myocardium by mobilizing bone marrow cells in rats Biochem Biophys Res Commun 349 2006 1242 1249
69. R. Di Stefano, M.C. Barsotti, and E. Melillo The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia Thromb Haemost 100 2008 871 877
70. J. Kawabe, K. Yuhki, and M. Okada Prostaglandin I2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling Arterioscler Thromb Vasc Biol 30 2010 464 470
71. L. Comini, T. Bachetti, and A. Cargnoni Therapeutic modulation of the nitric oxide: all ACE inhibitors are not equivalent Pharmacol Res 56 2007 42 48
72. R. Ferrari, and K. Fox Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story Drugs 69 2009 265 277
73. H. Li, and U. Förstermann Prevention of atherosclerosis by interference with the vascular nitric oxide system Curr Pharm Des 15 2009 3133 3145
74. C. Napoli, E. Ackah, and F. De Nigris Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice Proc Natl Acad Sci U S A 99 2002 12467 12470
75. F. de Nigris, F.P. Mancini, and M.L. Balestrieri Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits Nitric Oxide 19 2008 57 63
76. C. Napoli, and J. Loscalzo Nitric oxide and other novel therapies for pulmonary hypertension J Cardiovasc Pharmacol Ther 9 2004 1 8
77. B.S. Zuckerbraun, S. Shiva, and E. Ifedigbo Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation Circulation 121 2010 98 109
78. K.E. Broderick, L. Alvarez, and M. Balasubramanian Nitrosyl-cobinamide, a new and direct nitric oxide releasing drug effective in vivo Exp Biol Med (Maywood) 232 2007 1432 1440
79. P. Cabrales, G. Han, C. Roche, P. Nacharaju, A.J. Friedman, and J.M. Friedman Sustained release nitric oxide from long-lived circulating nanoparticles Free Radic Biol Med 49 2010 530 538
80. R.A. Smith, and M.P. Murphy Mitochondria-targeted antioxidants as therapies Discov Med 11 2011 106 114
81. T. Terai, and T. Nagano Fluorescent probes for bioimaging applications Curr Opin Chem Biol 12 2008 515 521
82. T. Nagano Bioimaging probes for reactive oxygen species and reactive nitrogen species J Clin Biochem Nutr 45 2009 111 124
83. L.E. McQuade, and S.J. Lippard Fluorescent probes to investigate nitric oxide and other reactive nitrogen species in biology (truncated form: fluorescent probes of reactive nitrogen species) Curr Opin Chem Biol 14 2010 43 49
84. J. Zhang, and H. Hong Selective fluorescent activation for bioimaging the expression of nitric oxide in cellular and in vivo systems Methods Mol Biol 704 2011 57 71